Delivery Order SPE2DB22D9362-SPE2DB24FY19B
Award Date 10/30/23
Potential Completion Date 10/31/23
Potential Value $3.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,107.70 by the Defense Logistics Agency Troop Support Medical to provide 50 milligrams per 0.5 milliliter syringes of Beyfortus. The delivery order was issued on October 25, 2023 against the prime vendor's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. As a leading pharmaceutical wholesaler, DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $7,243.12 by the Defense Logistics Agency to provide 50 milligrams per 0.5 milliliter syringes of Beyfortus. The delivery order was issued on October 30, 2023 against the company's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award....
- The Defense Logistics Agency awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The order, valued at $21,729.24, has a completion date of February 2, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the SPE2DB program, which has a ceiling value of up to $4,999,999 and supports...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand eight hundred one dollars and thirty-five cents ($4,801.35) by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. Under this delivery order, DMS Pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of BEYFORTUS 100 MG/ML SYRINGE/ML. The contract has a ceiling value of $1,629.58 and is set to expire on December 8, 2023. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of BEYFORTUS 100 MG/ML SYRINGE ML, a pharmaceutical product, with a potential value of $9,053.85. It is a firm fixed-price contract with a completion date of February 2, 2024. DMS Pharmaceutical Group is a pharmaceutical wholesaler that provides a range of prescription and over-the-counter...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand eight hundred one dollars and thirty-five cents ($4,801.35) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to five million dollars through December 2025. Under this...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide BEYFORTUS 100 MG/ML SYRINGEML. The contract has no set-aside designation, is valued at $22,420.45, and has a completion date of February 28, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a wide range of brand and generic prescription and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $50,490.00 firm fixed-price contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, with a period of performance through August 28, 2023. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,573.50, is for the delivery of the pharmaceutical product BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery...
- SPE2DB22D9362Indefinite Delivery Contract
- SPE2DB22D9362-SPE2DB24FY19BDelivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand six hundred twenty-one dollars and fifty-six cents ($3,621.56) by the Defense Logistics Agency to provide Beyfortus 50 MG/0.5 ML syringes. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to five million dollars through December 2025. No set-aside designation was used for this award. As a leading pharmaceutical wholesaler, DMS Pharmaceutical Group will deliver the Beyfortus syringes to support military treatment facilities operated by the Defense Logistics Agency.
Generated 1/29/24, 9:09 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 10/30/23 |